Use of YAKVINUS® (tofacitinib) for the treatment of rheumatoid arthritis
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 08.06.2018
Published: 08.06.2018
The author has read and approved the final manuscript.
Peer review info:
"Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
For citations:
Use of YAKVINUS® (tofacitinib) for the treatment of rheumatoid arthritis. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2014;(2):81-82.
(In Russ.)
Views:
597
Email this article 